0001493152-18-008650.txt : 20180613 0001493152-18-008650.hdr.sgml : 20180613 20180613215543 ACCESSION NUMBER: 0001493152-18-008650 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180611 FILED AS OF DATE: 20180613 DATE AS OF CHANGE: 20180613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PETERSON JEFFREY N CENTRAL INDEX KEY: 0001524090 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38185 FILM NUMBER: 18897991 MAIL ADDRESS: STREET 1: 1031 SHORELINE DRIVE CITY: SAN MATEO STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRESSURE BIOSCIENCES INC CENTRAL INDEX KEY: 0000830656 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 042652826 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14 NORFOLK AVENUE CITY: SOUTH EASTON STATE: MA ZIP: 02375 BUSINESS PHONE: 5082301828 MAIL ADDRESS: STREET 1: 14 NORFOLK AVENUE CITY: SOUTH EASTON STATE: MA ZIP: 02375 FORMER COMPANY: FORMER CONFORMED NAME: BOSTON BIOMEDICA INC DATE OF NAME CHANGE: 19960812 4 1 form4.xml X0306 4 2018-06-11 0 0000830656 PRESSURE BIOSCIENCES INC PBIO 0001524090 PETERSON JEFFREY N 110 WINCHESTER CT. FOSTER CITY CA 94404 1 0 0 0 SERIES AA CONVERTIBLE PREFERRED STOCK 2.50 2018-06-11 4 J 0 38.5 2500 A 2018-06-11 2019-06-11 COMMON STOCK 38500 38.5 D COMMON STOCK WARRANT 3.50 2018-06-11 4 J 0 38500 A 2018-06-11 2023-06-11 COMMON STOCK 38500 38500 D COMMON STOCK WARRANT 3.50 2018-06-11 4 J 0 2500 A 2016-03-31 2021-03-31 COMMON STOCK 2500 2500 D On June 11, 2018, Pressure BioSciences, Inc. (the "Issuer") entered into a letter agreement with Mr. Peterson (the "Reporting Person"). The Reporting Person previously held a convertible debenture with a face value of $46,200 (the "Debenture") and warrants to purchase common stock (the "Debenture Warrants"). Pursuant to the letter agreement, the Reporting Person agreed to convert the principal due to him pursuant to the Debenture into shares of Series AA Convertible Preferred Stock with a conversion price of $2.50 per share. The Reporting Person was also: (a) issued amended Debenture Warrants (originally issued on March 31, 2016) such that the exercise price is now $3.50 per share; and (b) issued a new warrant with an exercise price of $3.50 per share to purchase such number of shares of common stock as equal 100% of the number of shares of common stock issuable upon conversion of the Series AA Convertible Preferred Stock shares received as a result of the Debenture conversion. /s/ Jeffrey N. Peterson 2018-06-13